Eagle Pharmaceuticals, Inc. Operating Lease Cost
Eagle Pharmaceuticals, Inc. reported Operating Lease Cost of $400.00 thousand for the 3-month period ending 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2023-08-09
- Eagle Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2023-06-30 was $400.00K, a 0.00% change year-over-year.
- Eagle Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2023-03-31 was $421.00K, a 5.25% increase year-over-year.
- Eagle Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2022-12-31 was $334.00K, a 17.94% decline year-over-year.
- Eagle Pharmaceuticals, Inc. operating lease, cost for the quarter ending 2022-09-30 was $400.00K, a 33.33% increase year-over-year.
- Eagle Pharmaceuticals, Inc. operating lease, cost for fiscal 2021 was $1.41M, a 6.35% increase from fiscal 2020.
- Eagle Pharmaceuticals, Inc. operating lease, cost for fiscal 2020 was $1.32M, a 15.45% increase from fiscal 2019.
- Eagle Pharmaceuticals, Inc. operating lease, cost for fiscal 2019 was $1.15M.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 3 month as first filed | Operating Lease, Cost 6 month | Operating Lease, Cost 6 month as first filed | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|---|---|---|
| 2023-06-30 | $400.00K 10-Q/A · filed 2023-08-09 | $845.00K 10-Q/A · filed 2023-08-09 | $1.16M derived: sum of 3 quarters · filed 2023-08-09 | $1.55M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2023-03-31 | $421.00K 10-Q · filed 2023-05-09 | $755.00K derived: sum of 2 quarters · filed 2023-08-09 | $1.16M derived: sum of 3 quarters · filed 2023-08-09 | $1.55M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-12-31 | $334.00K derived: 10-Q/A 12 month − 10-Q 9 month · filed 2023-08-09 | $734.00K derived: sum of 2 quarters · filed 2023-08-09 | $1.13M derived: sum of 3 quarters · filed 2023-08-09 | $1.51M 10-Q/A · filed 2023-08-09 | ||
| 2022-09-30 | $400.00K 10-Q · filed 2022-11-09 | $800.00K derived: sum of 2 quarters · filed 2023-08-09 | $1.17M 10-Q · filed 2022-11-09 | $1.61M derived: sum of 4 quarters · filed 2023-08-09 | ||
| 2022-06-30 | $400.00K 10-Q/A · filed 2023-08-09 | $800.00K 10-Q/A · filed 2023-08-09 | $760.00K 10-Q · filed 2022-08-09 | $1.21M derived: sum of 3 quarters · filed 2023-08-09 | $1.51M derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $400.00K 10-Q · filed 2023-05-09 | $375.00K 10-Q · filed 2022-05-09 | $807.00K derived: sum of 2 quarters · filed 2023-05-09 | $1.11M derived: sum of 3 quarters · filed 2023-05-09 | $1.41M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $707.00K derived: sum of 2 quarters · filed 2023-03-23 | $1.01M derived: sum of 3 quarters · filed 2023-03-23 | $1.41M 10-K · filed 2023-03-23 | ||
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-09 | $600.00K derived: sum of 2 quarters · filed 2022-11-09 | $1.00M 10-Q · filed 2022-11-09 | $1.24M derived: sum of 4 quarters · filed 2023-03-23 | ||
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-09 | $700.00K 10-Q · filed 2022-08-09 | $943.00K derived: sum of 3 quarters · filed 2023-03-23 | $1.29M derived: sum of 4 quarters · filed 2023-03-23 | ||
| 2021-03-31 | $300.00K 10-Q · filed 2022-05-09 | $343.00K 10-Q · filed 2021-05-10 | $643.00K derived: sum of 2 quarters · filed 2023-03-23 | $986.00K derived: sum of 3 quarters · filed 2023-03-23 | $1.34M derived: sum of 4 quarters · filed 2023-03-23 | |
| 2020-12-31 | $343.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $686.00K derived: sum of 2 quarters · filed 2023-03-23 | $1.04M derived: sum of 3 quarters · filed 2023-03-23 | $1.32M 10-K · filed 2023-03-23 | ||
| 2020-09-30 | $343.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $694.00K derived: sum of 2 quarters · filed 2020-11-02 | $980.00K 10-Q · filed 2020-11-02 | $1.27M derived: sum of 4 quarters · filed 2022-03-08 | ||
| 2020-06-30 | $351.00K 10-Q · filed 2020-08-10 | $637.00K 10-Q · filed 2020-08-10 | $923.00K derived: sum of 3 quarters · filed 2022-03-08 | $1.21M derived: sum of 4 quarters · filed 2022-03-08 | ||
| 2020-03-31 | $286.00K 10-Q · filed 2020-05-11 | $572.00K derived: sum of 2 quarters · filed 2022-03-08 | $858.00K derived: sum of 3 quarters · filed 2022-03-08 | $1.14M derived: sum of 4 quarters · filed 2022-03-08 | ||
| 2019-12-31 | $286.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $572.00K derived: sum of 2 quarters · filed 2022-03-08 | $858.00K derived: sum of 3 quarters · filed 2022-03-08 | $1.15M 10-K · filed 2022-03-08 | ||
| 2019-09-30 | $286.00K 10-Q · filed 2019-11-12 | $572.00K derived: sum of 2 quarters · filed 2020-08-10 | $860.00K 10-Q · filed 2020-11-02 | |||
| 2019-06-30 | $286.00K 10-Q · filed 2020-08-10 | $573.00K 10-Q · filed 2020-08-10 | ||||
| 2019-03-31 | $287.00K 10-Q · filed 2020-05-11 |